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Background: During total cardiopulmonary bypass, blood flow to the lungs is
limited to flow through the bronchial arteries. We tested the hypothesis that
bronchial blood flow during cardiopulmonary bypass is insufficient to prevent
ischemia of the lung and that perfusion of the pulmonary arteries with oxygenated
blood during bypass would reduce lung injury.
Methods: Eighteen piglets (5.0  0.5 kg) were subjected to 120 minutes of
normothermic total cardiopulmonary bypass, followed by 60 minutes of postbypass
perfusion. Nine of them received continuous pulmonary perfusion with oxygenated
blood during bypass. Six additional piglets served as a control group and were
mechanically ventilated after sternotomy for 180 minutes only. We quantitated
bronchial arterial blood flow, tissue lactate content, and alveolar septal thickness and
surface area. We also obtained bronchioalveolar lavage fluid samples.
Results: With the beginning of cardiopulmonary bypass, bronchial arterial blood
flow decreased to 13% of baseline (42.1  10.4 to 5.6  1.0 mL/min). It remained
decreased until the end of bypass and returned to starting levels 60 minutes after
bypass. The decrease in bronchial blood flow was associated with a 3-fold increase
in tissue lactate content. At the end of reperfusion there was a 2-fold increase in
alveolar septal thickness and significant accumulations relative to control in the
bronchoalveolar lavage fluid of albumin, lactate dehydrogenase, neutrophils, and
elastase. Controlled pulmonary perfusion significantly ameliorated all the observed
changes.
Conclusion: Cardiopulmonary bypass caused a reduction in bronchial arterial blood
flow, which was associated with injury of the lung. Controlled pulmonary perfusion
reduced injury to the lung during bypass. The inflammatory response, as evidenced
by bronchoalveolar lavage fluid, may be caused by ischemia.
Pulmonary dysfunction is a frequent complication during the postop-erative course after cardiac surgery with cardiopulmonary bypass(CPB). Young age, preoperative pulmonary disease, and extendedduration of CPB are all risk factors for such dysfunction.1 CPB is alsoassociated with a complex whole-body inflammatory reaction thatmay contribute to the development of multiple organ dysfunction,
including postoperative lung injury.2-4 Recent investigations imply that pulmonary
dysfunction may be related to an ischemic injury of the lung during CPB.5 Because
blood flow to the lungs is limited to flow through the bronchial arteries during total
CPB, ischemic injury of the lung will occur if bronchial blood flow is insufficient
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to meet metabolic demands. When pulmonary blood flow
ceases, bronchial arterial blood flow might be expected to
increase as a compensatory measure. This expectation was
observed experimentally when in 1847 Virchow6 described an
increased bronchial flow after ligation of the pulmonary artery
(PA) in dogs. Thus far there are no reliable techniques avail-
able for the quantitation of bronchial arterial blood flow during
CPB. It is unknown whether the bronchial arterial blood flow
during total CPB is increased and whether it is sufficient to
prevent ischemic lung injury. It is also unknown whether the
reason for pulmonary dysfunction is related to ischemia of the
lung, an inflammatory reaction, or both. The aim of this study
was to quantitate bronchial arterial blood flow during CPB and
to assess the effects of controlled perfusion of the PA during
total CPB. Contrary to expectations, bronchial arterial blood
flow was substantially decreased during CPB, rendering the
lung ischemic, and controlled pulmonary perfusion was able to
reverse these changes.
Methods
Animals and Protocols
Male piglets (n  24, Deutsche Landrasse; Rein, Sulzfeld, Ger-
many) with a mean weight of 5.0  0.5 kg (equivalent to 4 weeks
of age) were used for the study. Use of the animals was approved
by the animal welfare committee of the University of Freiburg. All
animals received humane care in compliance with the “Guide for
the Care and Use of Laboratory Animals” prepared by the Institute
of Laboratory Animal Resources, National Research Council, and
published by the National Academy Press, revised 1996.
The animals were divided into three experimental groups.
Group 1 (conventional CPB, n  9) was subjected to 120 minutes
of normothermic total CPB without aortic crossclamping, followed
by normal unsupported circulation for 60 minutes (reperfusion).
Group 2 (CPB with PA perfusion, n  9) was treated as group 1
but also received controlled perfusion of the PA. Controlled per-
fusion was performed with oxygenated, normothermic, autologous
blood through a 6-mm polytetrafluoroethylene* tube, which was
anastomosed to the main PA and connected to the CPB circuit
beyond the membrane oxygenator. Lung perfusion was adjusted to
a maximal pressure of 20 mm Hg, which was equivalent to a blood
flow of 100 to 150 mL/min. During CPB, mechanical ventilation
was interrupted. A positive end-expiratory pressure of 4 to 5 mm
Hg was maintained for the duration of CPB. No protamine was
given at the end of CPB. Group 3 (control, n 6) served as control
and was ventilated after sternotomy for 180 minutes without
establishment of CPB. CPB was established as described previ-
ously elsewhere.7
Bronchial Arterial Blood Flow
Bronchial blood flow was determined with fluorescent microspheres
with four different color codes before CPB, at the beginning and at the
end of CPB, and after 60 minutes of reperfusion.7 Microspheres
(15.1  0.2 m diameter) were injected in a bolus (2  106 over 5
seconds) into the proximal aortic arch, distal to the arterial cannula.
The reference samples were withdrawn from the descending aorta at
the level of the diaphragm. The reliability of this approach was
verified by ensuring identical results obtained by injecting micro-
spheres into the left atrium or the aorta and collecting the references
sample in the descending aorta.7 At the end of the experiments, the
lungs were resected, the microspheres were filtered out of the digested
lung tissue, and the light emission of the fluorescent dye was quan-
titated as described previously elsewhere.7,8
Lung Tissue lactate
We determined lactate content of lung tissue as a marker for
anaerobic metabolism before CPB and at the end of CPB. To
assess the effects of the same period of total global ischemia on
lactate production, parts of 6 samples (all before CPB) were
subjected to 120 minutes of in vitro ischemia by being placed in a
vacuum-sealed plastic bag at 37°C in a water bath.
Bronchioalveolar Lavage
A bronchioalveolar lavage (BAL) was performed at the end of
reperfusion, as described by Riedler and colleagues.9 Cell counts
and solute components in the BAL fluid were analyzed.
Histologic Examination
At selected time points, samples were taken for histologic examina-
tion. At the end of the experiments, the lungs were explanted quickly
and divided into 14 segments according to a standardized pattern.
Tissue samples (25  25 mm) were taken out of each segment and
stored in a 4% formalin solution before the remaining lung tissue was
digested to filter out the microspheres. At the time of specimen
collection, the lungs were regularly ventilated. All histologic speci-
mens were embedded in paraffin and serially sectioned. The sections
were stained with hematoxylin and eosin, and alveolar septal thick-
ness and alveolar surface area were quantified in each specimen by
morphometric analysis (50 alveolar septa and 50 alveolar surface
areas per biopsy specimen after randomization; Soft Imaging System
GmbH, Mu¨nster, Germany). Comparisons between the two time
points were made between samples from the same side.
Hemodynamic Data
Standard hemodynamic monitoring was performed in all animals.
Arterial blood pressure was monitored continuously in the abdom-
inal aorta. Cardiac output was measured with a thermistor catheter
(Pulsion-Cold-System; Pulsion & Co Medical System KG,
Mu¨nchen, Germany) that was placed into the descending aorta.
Statistical Analysis
Statistical analysis was performed by repeated measures analysis
of variance with post hoc analysis by Newman-Keuls test. Values
are given as mean  SD.
Results
Hemodynamic Data
Table 1 shows cardiac outputs and aortic pressures before
and after CPB and pump flows and mean aortic pressures
during CPB. Pump flow was adjusted to match cardiac
output before CPB. Maintenance of this flow rate did not
result in significant changes in mean aortic pressure. During
*Gore-Tex; registered trademark of W. L. Gore & Associates, Inc, Flagstaff,
Ariz.
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reperfusion, both cardiac output and mean aortic pressure
were slightly lower than before CPB, although these
changes were not statistically significant.
Bronchial Blood Flow
Figure 1 shows bronchial blood flows before CPB, at the
beginning and end of CPB, and after 60 minutes of postby-
pass perfusion, either with or without controlled PA perfu-
sion. There was a significant decrease in bronchial blood
flow with the beginning of total CPB (5.6  1.0 mL/min vs
42.1  10.4 mL/min, or 0.7% vs 5.0% of cardiac output,
P  .01), which remained decreased until the end of CPB
(5.1  1.8 mL/min). Bronchial blood flow returned to
nearly normal values during 60 minutes of postbypass per-
fusion (25.6  10.8 mL/min). To examine the effects of
pulmonary perfusion on bronchial blood flow during CPB,
microsphere injections into the aorta were performed while
controlled perfusion to the PA was applied. The decrease in
bronchial blood flow during CPB was unaffected by pul-
monary perfusion (5.4  1.6 mL/min, P  .01 vs before
CPB) and also normalized during the reperfusion period
(34.7  13.5 mL/min).
Lung Tissue Lactate
Table 2 shows lactate contents of lung tissue before CPB
and at the end of CPB with or without controlled PA
perfusion. It also shows lactate content of lung tissue sub-
jected to 120 minutes of total global ischemia in the water
bath. During CPB, there was a 3-fold increase in tissue
lactate content. The same period of in vitro ischemia caused
a 10-fold increase in tissue lactate content. Controlled PA
perfusion attenuated the CPB-associated increase.
Histologic Examination
Figure 2 shows representative histologic specimens before
CPB and after CPB with or without controlled PA perfu-
sion. Figure 3, A, shows the average alveolar septal thick-
ness from tissue samples of lungs before CPB and at the end
of reperfusion after 120 minutes of CPB with or without
controlled PA perfusion. Figure 3, B, shows the average
alveolar surface area of the same samples. At the end of
reperfusion after CPB without PA perfusion, there was a
2-fold increase in alveolar septal thickness and a 50%
decrease in alveolar surface area relative to prebypass val-
ues. Both the increase in alveolar septal thickness and the
decrease in alveolar surface area were significantly reduced
by controlled PA perfusion relative to values after CPB
without PA perfusion. Alveolar septal thickness and alveo-
lar surface area were identical in all corresponding lung
areas.
Bronchioalveolar Lavage
Table 3 shows solute components and cell counts in BAL
fluids obtained before CPB and at the end of reperfusion
after 120 minutes of CPB with or without controlled PA
perfusion. At the end of reperfusion after CPB without PA
perfusion, there was a significant elevation of neutrophil
counts, albumin content and lactate dehydrogenase activity
in BAL fluid, which was not present in the group with
controlled PA perfusion.
Discussion
During CPB in piglets, bronchial arterial blood flow was
significantly reduced. This reduction in flow was indepen-
dent of pulmonary perfusion and was present despite unal-
tered systemic arterial perfusion pressure. It was associated
with metabolic and ultrastructural changes of lung tissue
suggesting the presence of ischemia of the lungs during
CPB, which could be ameliorated by controlled perfusion of
the PA. Furthermore, we demonstrated that indicators for an
inflammatory response of the lungs obtained from BAL
fluids could also be reversed by controlled perfusion of the
lung. Because blood flow to the lung is limited to flow
through the bronchial arteries during total CPB, bronchial
arterial blood flow might be expected to increase as a
compensatory measure to prevent ischemia of the lung.10
Bronchial arterial blood flow has been measured previously
in animals with a variety of techniques.11-15 However, the
results of these studies are inconclusive. Bronchial arterial
blood flow was found to be increased10 or decreased16 after
acute obstruction of the PA. During CPB, an estimate of
bronchial blood flow is possible by collecting the blood
returning to the vent catheter.11,12 Measurements of blood
flow with this technique are likely to be inaccurate, how-
ever, because bronchial blood flow can accumulate in the
lungs, and inadequate venting may occur during surgical
intervention.11 Also, no information on bronchial blood can
be obtained before or after CPB.
We assessed bronchial arterial blood flow with fluores-
cent microspheres before, during, and after CPB. In a pre-
vious study, we determined the accuracy of bronchial arte-
rial blood flow measurement with this method.7 We found
that the onset of CPB was associated with a persistent
TABLE 1. Cardiac output or pump flow during CPB and
mean arterial perfusion pressure before CPB, at the begin-
ning and end of CPB, and at the end of 60 minutes of
reperfusion
CO/pump flow
(mL  kg1  min1) MAP (mm Hg)
Before CPB 162 40 58 5
Beginning of CPB 178 42 65 6
End of CPB 184 34 65 9
After 60 min of reperfusion 134 34 55 10
Values are given mean  SD, n  18 in each group. CO, Cardiac output;
MAP, mean arterial pressure.
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decrease in bronchial arterial blood flow. Bronchial blood
flow normalized once physiologic perfusion conditions
were reestablished by terminating CPB. The reason for this
decrease in bronchial blood flow is currently not clear.
Bronchial blood flow is thought to be regulated by the
inflation state of the lung as well as by the pulmonary
perfusion pressure. The inflation state of the lung in our
study was maintained by keeping a positive end-expiratory
pressure of 5 mm Hg. Because there was no ventilation, it is
conceivable that carbon dioxide accumulated during CPB,
causing bronchial arterial constriction. However, the sudden
decrease in bronchial blood flow with the beginning of CPB
and the constancy of this value until the end of CPB argue
against this explanation. The absent pulmonary perfusion
pressure during total CPB has to be considered as another
potential explanation for our findings. For this reason, we
assessed bronchial blood flow during CPB while controlled
pulmonary perfusion was applied to maintain a physiolog-
ically usual pulmonary perfusion pressure. The decrease in
bronchial blood flow was unaffected by pulmonary perfu-
sion, eliminating this potential explanation. We therefore
conclude that the decrease in bronchial blood flow appears
to be a specific feature associated with CPB.
Because the perfusion pressure was unchanged with CPB
in our experiments, it seems reasonable to speculate that the
lack of pulsatile flow was responsible for the decreased
bronchial flow. Decreased organ perfusion during nonpul-
satile flow has been described for other organ systems (eg,
kidneys, splanchnic region).17,18 If this speculation is accu-
rate, the decrease in bronchial flow could be expected to be
worse in actual patients, because the mean perfusion pres-
sure is usually decreased with the beginning of CPB. One
way to approach this problem would be the use of pulsatile
CPB. Because of technical difficulties, the controversy of
quantifying pulsatility, and the lack of superior clinical
results, however, pulsatile perfusion has received only lim-
ited acceptance in clinical practice. Controlled pulmonary
perfusion may provide an alternative approach.
Figure 1. Bronchial arterial blood flows before CPB, at beginning and end of CPB with and without controlled PA
perfusion, and after 60 minutes of reperfusion. Bar heights represent mean; error bars represent SD; n  9 in each
group. Asterisk indicates P < .01 versus before CPB.
TABLE 2. Lactate content of lung tissue before CPB and
after 120 minutes of CPB without and with controlled PA
perfusion; additionally, separate tissue samples were ex-
posed to 120 minutes of total, global ischemia (in vitro
ischemia)
Tissue lactate
(mol/g dry weight)
Before CPB (n  6) 13.6 6.2
120 min of CPB without PA
perfusion (n  9)
36.5 10.9*
120 min of CPB with PA perfusion
(n  9)
25.4 12.3
120 min of in vitro ischemia (n  6) 133 33.9*†
Values are given as mean  SD. PA, Pulmonary artery.
*P  .05 versus before CPB.
†P  .05 versus after 120 minutes of CPB.
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We have demonstrated that perfusion of the lung with
normothermic, oxygenated blood during CPB can signifi-
cantly reduce metabolic and ultrastructural changes of lung
tissue. Similar parenchymal alterations have been reported
in children with pulmonary hypertension at the end of CPB
after surgical repair of congenital heart anomalies.19 In
infants younger than 6 months, the ultrastructural changes
(eg, increase in alveolar septal thickness) were correlated
with early death and prolonged mechanical ventilation.19
There is already clinical evidence that pulmonary perfusion
has beneficial effects on the maintenance of lung function in
infants.20,21 Continuous perfusion of the lung during CPB
resulted in a higher arterial oxygen tension in infants after
CPB than was seen with conventional CPB techniques.20
Suzuki and coworkers20 speculated that the impaired arterial
oxygen tension is related to ischemic injury of the lung
during conventional CPB. We provide experimental evi-
dence that this speculation is accurate. An unexpected ob-
servation was the prevention of changes caused by CPB in
the BAL fluids when the pulmonary arteries were perfused.
Accumulation of neutrophils and increases in lactate dehy-
drogenase and elastase activities in BAL fluids are consid-
ered indicators of an inflammatory response of the
lungs,22,23 which in turn is thought to be caused by the CPB
Figure 2. Representative light microscopic images of lung tissue (hematoxylin and eosin, original magnification
40) before CPB (A), after 120 minutes of CPB without PA perfusion (B), and after 120 minutes of CPB with
controlled PA perfusion (C).
Figure 3. Alveolar septal thickness (A) and alveolar surface area (B) before CPB and at the end of reperfusion after
CPB with or without controlled PA perfusion. Bar heights represent mean; error bars represent SD; n  9 in each
group. Asterisk indicates P < .01 versus before CPB; plus sign indicates P < .01 versus CPB without controlled
PA perfusion.
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circuit. If this were the case, pulmonary perfusion during
CPB should not have been able to affect these parameters.
Yet controlled perfusion of the PA prevented the accumu-
lation of neutrophils and the leakage of lactate dehydroge-
nase and elastase into the BAL fluids. This observation may
suggest a different pathologic mechanism for CPB-associ-
ated inflammatory changes, at least in lungs.
Clinical Relevance
A specific problem that may provide an example of the
clinical relevance of our conclusions is the treatment of
infants with single-ventricle physiology and shunt-depen-
dent pulmonary circulation. These patients may have to be
given postoperative mechanical support by extracorporeal
membrane oxygenation (ECMO).24-26 During ECMO, the
mode of perfusion is comparable to the mode during CPB.
The difference is the duration of support (days on ECMO vs
hours on CPB). This patient population has a poor outcome
after ECMO support, which among other things is due to
severe pulmonary dysfunction. Thus far, complete occlu-
sion of the systemic-pulmonary shunt has been recom-
mended to avoid an overcirculation to the lung and has been
performed by most surgeons.25 Recently, Jaggers and co-
workers24 left the shunt open while the patients were re-
ceiving ECMO support. In this small series of infants,
survival after ECMO support was improved relative to a
group of patients in whom the shunts were closed. Our
experimental finding that the bronchial arterial blood flow is
minimized during CPB may also hold true during ECMO,
although there may be still some antegrade flow to the right
ventricle. We demonstrated, however, that flow to the PA
did not affect the decrease in bronchial flow with the be-
ginning of CPB. Because perfusion of the lung with oxy-
genated blood during CPB was able to ameliorate the isch-
emic changes of the lung, the improved outcome of the infants
in whom the shunt was left open by Jaggers and coworkers24
may possibly be explained by the prevention of ischemia of the
lungs. These observations warrant further investigation.
We conclude that CPB causes a reduction in bronchial
arterial blood flow, which is associated with an injury of the
lung. Controlled pulmonary perfusion reduces injury to the
lung during CPB. The inflammatory response, as evidenced
by BAL fluid, may be caused by ischemia.
We thank Dr W.G. Williams (Hospital for Sick Children,
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